TNFRSF18 and myeloid sarcoma: We analyzed, in unfractionated peripheral blood mononuclear cells, several different markers, namely CD25, FoxP3, CTLA-4, GITR, and CD39, in the attempt to more precisely define Tregs and to identify the pattern that best describes their modulation during MS.